Source:http://linkedlifedata.com/resource/pubmed/id/12742636
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2003-5-13
|
pubmed:abstractText |
We evaluated the expression of two extra-cellular protease systems in a model of spontaneous cerebrovascular pathology: spontaneously hypertensive stroke-prone rats (SHRSP). The appearance of brain damage in individual animals was imaged and followed by means of magnetic resonance imaging (MRI). In situ zymography of brain slices obtained 3 days after the appearance of brain damage showed an increase in plasminogen activator (PA)/plasmin activity that co-localised with the cerebral damage detected by MRI; there was also concomitant accumulation/activation of inflammatory cells in the damaged area. Proteolytic activity was inhibited by the urokinase-specific inhibitor amiloride but not by an antibody against tissue-type plasminogen activator (t-PA). SDS-PAGE zymography of brain extracts revealed the presence of 58 kDa plasminogen-dependent lysis areas in the ischemic and non-ischemic tissues, and a 33 kDa lysis area in ischemic tissue only. An antibody against t-PA inhibited the former, whereas the latter was inhibited by amiloride. The specific induction of urokinase-type plasminogen activator (u-PA) in the damaged tissue was further confirmed by the fact that both u-PA protein mass and mRNA were markedly increased in the damaged cerebral areas. Concomitant metalloproteinase-2 (MMP-2) activation was only observed in the damaged area. These data suggest that u-PA is expressed and selectively catalyses proteolysis in the injured area of spontaneous brain damage in SHRSP.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Endopeptidases,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator,
http://linkedlifedata.com/resource/pubmed/chemical/Urokinase-Type Plasminogen Activator
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0006-8993
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
6
|
pubmed:volume |
974
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
184-92
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:12742636-Animals,
pubmed-meshheading:12742636-Blotting, Western,
pubmed-meshheading:12742636-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:12742636-Endopeptidases,
pubmed-meshheading:12742636-Magnetic Resonance Imaging,
pubmed-meshheading:12742636-Matrix Metalloproteinase 2,
pubmed-meshheading:12742636-Rats,
pubmed-meshheading:12742636-Rats, Inbred SHR,
pubmed-meshheading:12742636-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:12742636-Stroke,
pubmed-meshheading:12742636-Tissue Plasminogen Activator,
pubmed-meshheading:12742636-Urokinase-Type Plasminogen Activator
|
pubmed:year |
2003
|
pubmed:articleTitle |
Endogenous proteolytic activity in a rat model of spontaneous cerebral stroke.
|
pubmed:affiliation |
Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, Italy.
|
pubmed:publicationType |
Journal Article
|